High expression of TRAF1 in UCBs was positively associated with lymph node metastasis, tumor volume, and tumor recurrence (p < 0.05; Supplementary Table S3), and a poor prognosis in UCB patients (p < 0.05; Fig. D, E). This evidence concerns the gene TRAF1 and metastatic malignant neoplasm in the lymph nodes.